We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

77 hedge funds and large institutions have $421M invested in Translate Bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 12

125% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 8

15% more funds holding

Funds holding: 6777 (+10)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

19% less capital invested

Capital invested by funds: $521M → $421M (-$100M)

Holders
77
Holders Change
+10
Holders Change %
+14.93%
% of All Funds
1.52%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
18
Increased
30
Reduced
12
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$466K +$279K +30,185 +111%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$448K +$376K +40,776 +287%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$431K +$70.8K +7,677 +17%
JP Morgan Chase
29
JP Morgan Chase
New York
$429K +$386K +41,818 +387%
UBS Group
30
UBS Group
Switzerland
$402K +$318K +34,468 +231%
VEA
31
Virtus ETF Advisers
New York
$388K +$440K +47,685 New
State of Wisconsin Investment Board
32
State of Wisconsin Investment Board
Wisconsin
$349K
Swiss National Bank
33
Swiss National Bank
Switzerland
$327K +$371K +40,200 New
Barclays
34
Barclays
United Kingdom
$324K +$197K +21,316 +115%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$314K +$13K +1,413 +4%
Ensign Peak Advisors
36
Ensign Peak Advisors
Utah
$308K +$349K +37,849 New
AGM
37
Alpine Global Management
New York
$266K +$301K +32,663 New
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$259K +$16.6K +1,800 +6%
AllianceBernstein
39
AllianceBernstein
Tennessee
$256K +$38.8K +4,200 +15%
AGA
40
Altrinsic Global Advisors
Connecticut
$244K +$277K +30,000 New
FAM
41
Fred Alger Management
New York
$195K +$120K +13,000 +118%
Squarepoint
42
Squarepoint
New York
$193K +$99.6K +10,797 +84%
AIG
43
American International Group
New York
$177K +$29K +3,140 +17%
Legal & General Group
44
Legal & General Group
United Kingdom
$164K +$140K +15,193 +307%
FAAS
45
First Allied Advisory Services
California
$155K +$55.4K +6,000 +46%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$152K -$5.7K -618 -3%
EGM
47
Engineers Gate Manager
New York
$145K +$164K +17,800 New
ProShare Advisors
48
ProShare Advisors
Maryland
$144K +$4.82K +522 +3%
VOYA Investment Management
49
VOYA Investment Management
Georgia
$137K +$43.9K +4,758 +40%
MIM
50
MetLife Investment Management
New Jersey
$132K

TBIO Hedge Fund Activity: Q4 2019 in Review

77 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q4 2019, worth a combined $421M — down 19% from $521M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TBIO positions and 8 closed out — a net gain of 10 holders — while 30 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock, adding an estimated $3.45M. The largest seller was Citigroup, cutting an estimated $7.65M.

  • 77 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q4 2019, up from 67 in Q3 2019.
  • Funds reported $421M of Translate Bio, Inc. Common Stock stock for Q4 2019, down 19% quarter-over-quarter.
  • 18 funds opened new Translate Bio, Inc. Common Stock positions in Q4 2019 and 8 closed out, a net change of +10 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q4 2019 was BlackRock, an estimated $3.45M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q4 2019 was Citigroup, an estimated $7.65M sold.

Based on aggregated 13F filings for Q4 2019.